Clinquest Group Closes Up To $5.5 Million Funding By BioGenetics Capital

HUDSON, Mass.--(BUSINESS WIRE)--Dec. 21, 2005--In a business milestone following years of steady growth and profitability, Clinquest Group(TM), a global life sciences product development and clinical trials services company serving the bio-pharmaceutical, medical device and medical data industries, today announced that it has successfully closed an up to $5.5 million financing round with BioGenetics Capital Pte Ltd.

MORE ON THIS TOPIC